主页文献库搜索
Constitutively activated PI3K accelerates tumor initiation and modifies histo...

Sheen(M R),Marotti(J D),Allegrezza(M J),Ru... Oncogenesis 0000-00-00

The gene encoding phosphatidylinositol 3-kinase catalytic subunit α-isoform (PIK3CA, p110α) is frequently activated by m...

Mutational landscape of uterine and ovarian carcinosarcomas implicates histon...

Zhao(Siming),Bellone(Stefania),Lopez(Salva... Proc Natl Acad Sci U S A 0000-00-00

...PIK3CA, PPP2R1A, KRAS, PTEN, CHD4, and BCOR, we found an excess of mutations in genes encoding histone H2A and H2B, as w...

Investigation of EZH2 pathways for novel epigenetic treatment strategies in o...

Idris(Sherif),Lindsay(Cameron),Kostiuk(Mor... J Otolaryngol Head Neck Sur... 0000-00-00

...PIK3CA, but remained unchanged for EGFR, CDKN2A and p53.,Inhibition of EZH2 has anti-tumorigenic effects on OPSCC cells ...

Analytical evaluation for somatic mutation detection in circulating tumor cel...

Cho(Hyungseok),Kim(Jinho),Han(Song-I),Han(... Biomed Microdevices 0000-00-00

...PIK3CA and APC) of MCF7 cells were evaluated in the isolated samples. The results showed that somatic mutations could be...

Clinical implications of routine genomic mutation sequencing in PIK3CA/AKT1 a...

Cejalvo(Juan Miguel),Pérez-Fidalgo(J Aleja... Breast Cancer Res Treat 0000-00-00

...PIK3CA, AKT1, KRAS, NRAS, and BRAF in order to select patients for targeted therapy clinical trials. The genomes of arch...

The possible roles of B-cell novel protein-1 (BCNP1) in cellular signalling p...

Patel(Sapan J),Trivedi(Gaurang L),Darie(Co... J Cell Mol Med 0000-00-00

...PIK3CA (Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha), MAPK1 (mitogen-activated protein kinas...

Diagnostic application of PIK3CA mutation analysis in Chinese esophageal canc...

Ming(Zizhen),Jiang(Dongxian),Hu(Qin),Li(Xi... Diagn Pathol 0000-00-00

...PIK3CA gene mutation in EC.,Genomic DNA was extracted from 106 surgically resected EC patient tissues. The PIK3CA mutati...

Hormone Therapy plus mTOR Inhibitors in the Treatment of Endometrial Carcinom...

Stringer(Erica M),Fleming(Gini F) Oncol Hematol Rev 0000-00-00

...PIK3CA, and mutations in PIK3R1, are very common in endometrial carcinomas. mTOR inhibitors, including temsirolimus, eve...

The determinants of head and neck cancer: Unmasking the PI3K pathway mutation...

Giudice(Fernanda S),Squarize(Cristiane H) J Carcinog Mutagen 0000-00-00

...PIK3CA and PTEN are key molecules in the PI3K-PTEN-mTOR signaling pathway. In this review, we provided a comprehensive o...

[Correlation between the incidence of PIK3CA mutations in breast cancer and h...

Mendelová(A),Jezková(E),Zubor(P),Holubekov... Ceska Gynekol 0000-00-00

...PIK3CA mutations and some clinicopathological characteristics of tumour. We have shown that the mutations in exon 9 of P...

上一页 347 348 349 350 351 352 353 下一页 351 / 共 353

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: product@genelibs.com